RECURSION PHARMACEUTICALS, INC. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Recursion Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Recursion Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $4M, a 4.76% decline year-over-year.
  • Recursion Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2024 was $16.2M, a 8.73% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. annual Depreciation for 2023 was $15.9M, a 39.5% increase from 2022.
  • Recursion Pharmaceuticals, Inc. annual Depreciation for 2022 was $11.4M, a 29.5% increase from 2021.
  • Recursion Pharmaceuticals, Inc. annual Depreciation for 2021 was $8.8M, a 110% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15.9M +$4.5M +39.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $11.4M +$2.6M +29.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $8.8M +$4.6M +110% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $4.2M +$700K +20% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $3.5M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.